3Waring S C, Rocca W A, Petersen R C, et al. Post menopausal estrogen replacement therapy and risk of AD: a population-based study[J]. Neurology, 1999,52 (5) : 965-970.
4Sherwin B B. Estrogen and cognitive aging in women[J]. Trends Pharmacol Sci, 2002,23 ( 11 ) : 527-534.
5Cyr M,Calon F, Morissett E M, et al. Estrogenic mod- ulation of brain activity:implications for schizophrenia and Parkinson's disease[J].Psychiatry Neurosci, 2002, 27 : 12-27.
6Yuan J, Yankner B A. Apoptosis in the nervous system [J]. Nature,2000,407(6805) : 802-809.
7Osterlund M, KuiPR O G, Gusfasson J, et al. Differential distribution and regulation of estrogen reeetyor-alpha and - beta mRNA within the female rat brain [J].Brain Res,1998,54(1) : 175-180.
8Suresh B P,Jenny M J,Robert D K. Treatment of rats with 17β-estradiol or relaxin rapidly inhibits uterine estrogen receptor β1 and β2 messenger ribonucleic acid levels[J]. Biol Reprod, 2002,67 : 1919-1926.
9Louis J P,Ann S P,Anna J C. A sterotaxic atlas of the rat brain[M]. New York and London: Plenum Press,1979.
10Green P S, Simpkins J W. Neuro protectiveeffects of estrogen: potential mechanisms of action[J].Int Dev Neurosci,2000,18 : 347-358.
